Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic active hepatitis in the elderly.

C D Selby, P J Toghill

    Age and Ageing
    |November 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Autoimmune chronic active hepatitis can affect the elderly, with patients over 70 responding well to standard immunosuppressive therapy. Diagnosis and treatment for older adults should mirror that of younger individuals.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The war's impact and influence on industrial medicine.

    Industrial medicine & surgery·2010
    Same author

    Other people's lives.

    British medical journal·2010
    Same author

    Abdominal pain associated with cranial nerve palsy and peripheral neuropathy.

    Postgraduate medical journal·1997
    Same author

    CME-certification by the European Board of Gastroenterology.

    Gut·1997
    Same author

    Neurological complications of celiac disease: a rare but continuing problem.

    The American journal of gastroenterology·1996
    Same author

    'Relapse' of chronic active hepatitis--not always what it seems.

    Postgraduate medical journal·1996
    Same journal

    Overlapping premorbid frailty, multimorbidity and malnutrition and their associations with poor outcomes in patients with stroke.

    Age and ageing·2026
    Same journal

    Overall and cause-specific mortality and associated risk factors among middle-aged and older South Africans: findings from the health and ageing in Africa: a longitudinal study of an INDEPTH community in rural South Africa (HAALSI).

    Age and ageing·2026
    Same journal

    Effect of antihypertensive medication reduction on short-term blood pressure control in older adults: calibration of OPTiMISE trial results to real-world primary care data.

    Age and ageing·2026
    Same journal

    New horizons in advance care planning: narratives, identity and cultural humility.

    Age and ageing·2026
    Same journal

    Correction to: How a geriatrician-led emergency department model works in practice: a realist evaluation.

    Age and ageing·2026
    Same journal

    Effects of a home-based exercise and physical activity intervention after inpatient rehabilitation on real-world mobility in older adults with cognitive impairment: a secondary analysis of a randomised controlled trial.

    Age and ageing·2026
    See all related articles

    Area of Science:

    • Hepatology
    • Immunology
    • Geriatric Medicine

    Background:

    • Autoimmune chronic active hepatitis (AICAH) is a liver disease where the immune system attacks liver cells.
    • The occurrence and management of AICAH in elderly populations are not well-established.

    Observation:

    • Five new cases of AICAH were diagnosed in patients aged 70 years and older.
    • These elderly patients tolerated liver biopsies and follow-up procedures well.

    Findings:

    • AICAH occurs in the elderly population.
    • Patients over 70 years old responded positively to conventional immunosuppressive therapy.
    • Immunosuppressive agents are effective and well-tolerated in elderly AICAH patients.

    Implications:

    Related Experiment Videos

    • AICAH management in the elderly should align with that of younger patients.
    • There is no clinical reason to withhold immunosuppressive therapy in elderly patients with AICAH.
    • This study supports the inclusion of elderly individuals in AICAH treatment protocols.